Table of Contents
Journal of Signal Transduction
Volume 2011, Article ID 738137, 18 pages
http://dx.doi.org/10.1155/2011/738137
Review Article

Integrin Signaling, Cell Survival, and Anoikis: Distinctions, Differences, and Differentiation

1Département d'Anatomie et de Biologie Cellulaire, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC, Canada J1H 5N4
2Thématique de Recherche en Physiopathologie Digestive du Centre de Recherches Cliniques Étienne-Le Bel, Centre Hospitalier Universitaire de Sherbrooke, Campus Fleurimont, Sherbrooke, QC, Canada J1H 5N4

Received 12 September 2010; Revised 6 January 2011; Accepted 10 March 2011

Academic Editor: A. Yoshimura

Copyright © 2011 Pierre H. Vachon. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Edinger and C. B. Thompson, “Death by design: apoptosis, necrosis and autophagy,” Current Opinion in Cell Biology, vol. 16, no. 6, pp. 663–669, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. C. A. Guimarães and R. Linden, “Programmed cell death: apoptosis and alternative deathstyles,” European Journal of Biochemistry, vol. 271, no. 9, pp. 1638–1650, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. N. N. Danial and S. J. Korsmeyer, “Cell death: critical control points,” Cell, vol. 116, no. 2, pp. 205–219, 2004. View at Publisher · View at Google Scholar
  4. C. Penaloza, S. Orlanski, Y. Ye, T. Entezari-Zaher, M. Javdan, and Z. Zakeri, “Cell death in mammalian development,” Current Pharmaceutical Design, vol. 14, no. 2, pp. 184–196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Zakeri and R. A. Lockshin, “Cell death: history and future,” Advances in Experimental Medicine and Biology, vol. 615, pp. 1–11, 2008. View at Publisher · View at Google Scholar
  6. J. Colin, S. Gaumer, I. Guenal, and B. Mignotte, “Mitochondria, Bcl-2 family proteins and apoptosomes: of worms, flies and men,” Frontiers in Bioscience, vol. 14, pp. 4127–4137, 2009. View at Google Scholar
  7. A. Eisenberg-Lerner, S. Bialik, H. U. Simon, and A. Kimchi, “Life and death partners: apoptosis, autophagy and the cross-talk between them,” Cell Death and Differentiation, vol. 16, no. 7, pp. 966–975, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Levine, S. Sinha, and G. Kroemer, “Bcl-2 family members: dual regulators of apoptosis and autophagy,” Autophagy, vol. 4, no. 5, pp. 600–606, 2008. View at Google Scholar · View at Scopus
  9. H. M. Heath-Engel, N. C. Chang, and G. C. Shore, “The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family,” Oncogene, vol. 27, no. 50, pp. 6419–6433, 2008. View at Publisher · View at Google Scholar
  10. G. Kroemer, L. Galluzzi, P. Vandenabeele et al., “Classification of cell death: recommendations of the nomenclature committee on cell death 2009,” Cell Death and Differentiation, vol. 16, no. 1, pp. 3–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Cory, D. C. S. Huang, and J. M. Adams, “The Bcl-2 family: roles in cell survival and oncogenesis,” Oncogene, vol. 22, no. 53, pp. 8590–8607, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. S. S. Martin and K. Vuori, “Regulation of Bcl-2 proteins during anoikis and amorphosis,” Biochimica et Biophysica Acta, vol. 1692, no. 2-3, pp. 145–157, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. R. Elliott and K. S. Ravichandran, “Clearance of apoptotic cells: implications in health and disease,” Journal of Cell Biology, vol. 189, no. 7, pp. 1059–1070, 2010. View at Publisher · View at Google Scholar
  14. J. M. Adams and S. Cory, “Bcl-2-regulated apoptosis: mechanism and therapeutic potential,” Current Opinion in Immunology, vol. 19, no. 5, pp. 488–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Adams and S. Cory, “The Bcl-2 apoptotic switch in cancer development and therapy,” Oncogene, vol. 26, no. 9, pp. 1324–1337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. W. Yip and J. C. Reed, “Bcl-2 family proteins and cancer,” Oncogene, vol. 27, no. 50, pp. 6398–6406, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. R. J. Youle and A. Strasser, “The BCL-2 protein family: opposing activities that mediate cell death,” Nature Reviews Molecular Cell Biology, vol. 9, no. 1, pp. 47–59, 2008. View at Publisher · View at Google Scholar
  18. S. J. Riedl and G. S. Salvesen, “The apoptosome: signalling platform of cell death,” Nature Reviews Molecular Cell Biology, vol. 8, no. 5, pp. 405–413, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. C. Timmer and G. S. Salvesen, “Caspase substrates,” Cell Death and Differentiation, vol. 14, no. 1, pp. 66–72, 2007. View at Publisher · View at Google Scholar
  20. P. Fuentes-Prior and G. S. Salvesen, “The protein structures that shape caspase activity, specificity, activation and inhibition,” Biochemical Journal, vol. 384, no. 2, pp. 201–232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Hunter, E. C. LaCasse, and R. G. Korneluk, “The inhibitors of apoptosis (IAPs) as cancer targets,” Apoptosis, vol. 12, no. 9, pp. 1543–1568, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S. M. Srinivasula and J. D. Ashwell, “IAPs: what's in a name?” Molecular Cell, vol. 30, no. 2, pp. 123–135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. P. G. Ekert and D. L. Vaux, “The mitochondrial death squad: hardened killers or innocent bystanders?” Current Opinion in Cell Biology, vol. 17, no. 6, pp. 626–630, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. J. K. Brunelle and A. Letai, “Control of mitochondrial apoptosis by the Bcl-2 family,” Journal of Cell Science, vol. 122, no. 4, pp. 437–441, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Basu, G. DuBois, and S. Haldar, “Posttranslational modifications of Bcl2 family members—a potential therapeutic target for human malignancy,” Frontiers in Bioscience, vol. 11, no. 2, pp. 1508–1521, 2006. View at Google Scholar · View at Scopus
  26. O. Kutuk and A. Letai, “Regulation of Bcl-2 family proteins by posttranslational modifications,” Current Molecular Medicine, vol. 8, no. 2, pp. 102–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. L. P. Billen, A. Shamas-Din, and D. W. Andrews, “Bid: ABax-like BH3 protein,” Oncogene, vol. 27, supplement 1, pp. S93–S104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. N. N. Danial, “BAD: undertaker by night, candyman by day,” Oncogene, vol. 27, supplement 1, pp. S53–S70, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Chen and J. Wang, “Initiator caspases in apoptosis signaling pathways,” Apoptosis, vol. 7, no. 4, pp. 313–319, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Walczak and T. L. Haas, “Biochemical analysis of the native TRAIL death-inducing signaling complex,” Methods in Molecular Biology, vol. 414, pp. 221–239, 2007. View at Google Scholar · View at Scopus
  31. J. Li and J. Yuan, “Caspases in apoptosis and beyond,” Oncogene, vol. 27, no. 48, pp. 6194–6206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. N. S. Wilson, V. Dixit, and A. Ashkenazi, “Death receptor signal transducers: nodes of coordination in immune signaling networks,” Nature Immunology, vol. 10, no. 4, pp. 348–355, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. N. J. Boudreau and P. L. Jones, “Extracellular matrix and integrin signalling: the shape of things to come,” Biochemical Journal, vol. 339, no. 3, pp. 481–488, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. P. J. Reddig and R. L. Juliano, “Clinging to life: cell to matrix adhesion and cell survival,” Cancer and Metastasis Reviews, vol. 24, no. 3, pp. 425–439, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Marastoni, G. Ligresti, E. Lorenzon, A. Colombatti, and M. Mongiat, “Extracellular matrix: a matter of life and death,” Connective Tissue Research, vol. 49, no. 3-4, pp. 203–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. A. P. Gilmore, T. W. Owens, F. M. Foster, and J. Lindsay, “How adhesion signals reach a mitochondrial conclusion—ECM regulation of apoptosis,” Current Opinion in Cell Biology, vol. 21, no. 5, pp. 654–661, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. R. O. Hynes, “The extracellular matrix: not just pretty fibrils,” Science, vol. 326, no. 5957, pp. 1216–1219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Rozario and D. W. DeSimone, “The extracellular matrix in development and morphogenesis: a dynamic view,” Developmental Biology, vol. 341, no. 1, pp. 126–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Van der Flier and A. Sonnenberg, “Function and interactions of integrins,” Cell and Tissue Research, vol. 305, no. 3, pp. 285–298, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Armulik, “Splice variants of human beta 1 integrins: origin, biosynthesis and functions,” Frontiers in Bioscience, vol. 7, pp. d219–227, 2002. View at Google Scholar
  41. R. O. Hynes, “Integrins: bidirectional, allosteric signaling machines,” Cell, vol. 110, no. 6, pp. 673–687, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. J. A. Askari, P. A. Buckley, A. P. Mould, and M. J. Humphries, “Linking integrin conformation to function,” Journal of Cell Science, vol. 122, no. 2, pp. 165–170, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. C. G. Gahmberg, S. C. Fagerholm, S. M. Nurmi, T. Chavakis, S. Marchesan, and M. Grönholm, “Regulation of integrin activity and signalling,” Biochimica et Biophysica Acta, vol. 1790, no. 6, pp. 431–444, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. E. H. Danen and A. Sonnenberg, “Integrins in regulation of tissue development and function,” The Journal of Pathology, vol. 201, no. 4, pp. 632–641, 2003. View at Google Scholar · View at Scopus
  45. J. E. Meredith, B. Fazeli, and M. A. Schwartz, “The extracellular matrix as a cell survival factor,” Molecular Biology of the Cell, vol. 4, no. 9, pp. 953–961, 1993. View at Google Scholar · View at Scopus
  46. S. M. Frisch and H. Francis, “Disruption of epithelial cell-matrix interactions induces apoptosis,” Journal of Cell Biology, vol. 124, no. 4, pp. 619–626, 1994. View at Google Scholar · View at Scopus
  47. J. E. Meredith and M. A. Schwartz, “Integrins, adhesion and apoptosis,” Trends in Cell Biology, vol. 7, no. 4, pp. 146–150, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. F. G. Giancotti, “Complexity and specificity of integrin signalling,” Nature Cell Biology, vol. 2, no. 1, pp. E13–E14, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. A. L. Berrier and K. M. Yamada, “Cell-matrix adhesion,” Journal of Cellular Physiology, vol. 213, no. 3, pp. 565–573, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. P. H. Vachon, F. Loechel, H. Xu, U. M. Wewer, and E. Engvall, “Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival,” Journal of Cell Biology, vol. 134, no. 6, pp. 1483–1497, 1996. View at Google Scholar · View at Scopus
  51. P. H. Vachon, H. Xu, L. Liu et al., “Integrins (α7β1) in muscle function and survival disrupted expression in merosin-deficient congenital muscular dystrophy,” Journal of Clinical Investigation, vol. 100, no. 7, pp. 1870–1881, 1997. View at Google Scholar · View at Scopus
  52. P. Laprise, È.-M. Poirier, A. Vézina, N. Rivard, and P. H. Vachon, “Merosin-integrin promotion of skeletal myofiber cell survival: differentiation state-distinct involvement of p60Fyn tyrosine kinase and p38α stress-activated MAP kinase,” Journal of Cellular Physiology, vol. 191, no. 1, pp. 69–81, 2002. View at Publisher · View at Google Scholar
  53. P. Laprise, K. Vallée, M.-J. Demers et al., “Merosin (laminin-2/4)-driven survival signaling: complex modulations of Bcl-2 homologs,” Journal of Cellular Biochemistry, vol. 89, no. 6, pp. 1115–1125, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. J. E. Rooney, P. B. Gurpur, Z. Yablonka-Reuveni, and D. J. Burkin, “Laminin-111 restores regenerative capacity in a mouse model for α7 integrin congenital myopathy,” American Journal of Pathology, vol. 174, no. 1, pp. 256–264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. J. E. Rooney, P. B. Gurpur, and D. J. Burkin, “Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 19, pp. 7991–7996, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. K. I. Gawlik, M. Åkerlund, V. Carmignac, H. Elamaa, and M. Durbeej, “Distinct roles for laminin globular domains in laminin α1 chain mediated rescue of murine laminin α2 chain deficiency,” PLoS ONE, vol. 5, no. 7, Article ID e11549, 2010. View at Publisher · View at Google Scholar
  57. K. I. Gawlik, U. Mayer, K. Blomberg, A. Sonnenberg, P. Ekblom, and M. Durbeej, “Laminin α1 chain mediated reduction of laminin α2 chain deficient muscular dystrophy involves integrin α7β1 and dystroglycan,” FEBS Letters, vol. 580, no. 7, pp. 1759–1765, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. F. G. Giancotti, “Integrin signaling: specificity and control of cell survival and cell cycle progression,” Current Opinion in Cell Biology, vol. 9, no. 5, pp. 691–700, 1997. View at Publisher · View at Google Scholar · View at Scopus
  59. F. G. Giancotti and E. Ruoslahti, “Integrin signaling,” Science, vol. 285, no. 5430, pp. 1028–1032, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. D. G. Stupack and D. A. Cheresh, “Get a ligand, get a life: integrins, signaling and cell survival,” Journal of Cell Science, vol. 115, no. 19, pp. 3729–3738, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. D. S. Harburger and D. A. Calderwood, “Integrin signalling at a glance,” Journal of Cell Science, vol. 122, no. 2, pp. 159–163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Cabodi, P. Di Stefano, M. P. Leal et al., “Integrins and signal transduction,” Advances in Experimental Medicine and Biology, vol. 674, pp. 43–54, 2010. View at Google Scholar
  63. J. T. Parsons, “Focal adhesion kinase: the first ten years,” Journal of Cell Science, vol. 116, no. 8, pp. 1409–1416, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. M. C. Frame, “Newest findings on the oldest oncogene; how activated src does it,” Journal of Cell Science, vol. 117, no. 7, pp. 989–998, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. S. J. Parsons and J. T. Parsons, “Src family kinases, key regulators of signal transduction,” Oncogene, vol. 23, no. 48, pp. 7906–7909, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. M. P. Playford and M. D. Schaller, “The interplay between Src and integrins in normal and tumor biology,” Oncogene, vol. 23, no. 48, pp. 7928–7946, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. L. A. Cohen and J. L. Guan, “Mechanisms of focal adhesion kinase regulation,” Current Cancer Drug Targets, vol. 5, no. 8, pp. 629–643, 2005. View at Google Scholar · View at Scopus
  68. G. W. McLean, N. O. Carragher, E. Avizienyte, J. Evans, V. G. Brunton, and M. C. Frame, “The role of focal-adhesion kinase in cancer—a new therapeutic opportunity,” Nature Reviews Cancer, vol. 5, no. 7, pp. 505–515, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. S. K. Mitra and D. D. Schlaepfer, “Integrin-regulated FAK-Src signaling in normal and cancer cells,” Current Opinion in Cell Biology, vol. 18, no. 5, pp. 516–523, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. V. G. Brunton and M. C. Frame, “Src and focal adhesion kinase as therapeutic targets in cancer,” Current Opinion in Pharmacology, vol. 8, no. 4, pp. 427–432, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. E. Ingley, “Src family kinases: regulation of their activities, levels and identification of new pathways,” Biochimica et Biophysica Acta, vol. 1784, no. 1, pp. 56–65, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Zhao and J. L. Guan, “Signal transduction by focal adhesion kinase in cancer,” Cancer and Metastasis Reviews, vol. 28, no. 1-2, pp. 35–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. P. P. Provenzano and P. J. Keely, “The role of focal adhesion kinase in tumor initiation and progression,” Cell Adhesion and Migration, vol. 3, no. 4, pp. 347–350, 2009. View at Google Scholar · View at Scopus
  74. E. G. Arias-Salgado, S. Lizano, S. Sarkar, J. S. Brugge, M. H. Ginsberg, and S. J. Shattil, “Src kinase activation by direct interaction with the integrin β cytoplasmic domain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 23, pp. 13298–13302, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. K. H. Martin, J. K. Slack, S. A. Boerner, C. C. Martin, and J. T. Parsons, “Integrin connections map: to infinity and beyond,” Science, vol. 296, no. 5573, pp. 1652–1653, 2002. View at Publisher · View at Google Scholar · View at Scopus
  76. K. R. Legate and R. Fässler, “Mechanisms that regulate adaptor binding to β-integrin cytoplasmic tails,” Journal of Cell Science, vol. 122, no. 2, pp. 187–198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. K. R. Legate, E. Montañez, O. Kudlacek, and R. Fässler, “ILK, PINCH and parvin: the tIPP of integrin signalling,” Nature Reviews Molecular Cell Biology, vol. 7, no. 1, pp. 20–31, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. R. T. Böttcher, A. Lange, and R. Fässler, “How ILK and kindlins cooperate to orchestrate integrin signaling,” Current Opinion in Cell Biology, vol. 21, no. 5, pp. 670–675, 2009. View at Publisher · View at Google Scholar · View at Scopus
  79. K. Wilhelmsen, S. H. M. Litjens, and A. Sonnenberg, “Multiple functions of the integrin α6β4 in epidermal homeostasis and tumorigenesis,” Molecular and Cellular Biology, vol. 26, no. 8, pp. 2877–2886, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Z. Gilcrease, “Integrin signaling in epithelial cells,” Cancer Letters, vol. 247, no. 1-2, pp. 1–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. J. Grossmann, “Molecular mechanisms of "detachment-induced apoptosis—anoikis",” Apoptosis, vol. 7, no. 3, pp. 247–260, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. C. Wu and S. Dedhar, “Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes,” Journal of Cell Biology, vol. 155, no. 3, pp. 505–510, 2001. View at Google Scholar · View at Scopus
  83. G. Hannigan, A. A. Troussard, and S. Dedhar, “Integrin-linked kinase: a cancer therapeutic target unique among its ILK,” Nature Reviews Cancer, vol. 5, no. 1, pp. 51–63, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. P. C. McDonald, A. B. Fielding, and S. Dedhar, “Integrin-linked kinase—essential roles in physiology and cancer biology,” Journal of Cell Science, vol. 121, no. 19, pp. 3121–3132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. E. N. Pugacheva, F. Roegiers, and E. A. Golemis, “Interdependence of cell attachment and cell cycle signaling,” Current Opinion in Cell Biology, vol. 18, no. 5, pp. 507–515, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. S. Hehlgans, M. Haase, and N. Cordes, “Signalling via integrins: implications for cell survival and anticancer strategies,” Biochimica et Biophysica Acta, vol. 1775, no. 1, pp. 163–180, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. M. A. Lemmon and J. Schlessinger, “Cell signaling by receptor tyrosine kinases,” Cell, vol. 141, no. 7, pp. 1117–1134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Osaki, M. Oshimura, and H. Ito, “PI3K-Akt pathway: its functions and alterations in human cancer,” Apoptosis, vol. 9, no. 6, pp. 667–676, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. D. Kim, H. C. Dan, S. Park et al., “AKT/PKB signaling mechanisms in cancer and chemoresistance,” Frontiers in Bioscience, vol. 10, pp. 975–987, 2005. View at Google Scholar · View at Scopus
  90. B. D. Manning and L. C. Cantley, “AKT/PKB signaling: navigating downstream,” Cell, vol. 129, no. 7, pp. 1261–1274, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. V. Duronio, “The life of a cell: apoptosis regulation by the PI3K/PKB pathway,” Biochemical Journal, vol. 415, no. 3, pp. 333–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Parcellier, L. A. Tintignac, E. Zhuravleva, and B. A. Hemmings, “PKB and the mitochondria: AKTing on apoptosis,” Cellular Signalling, vol. 20, no. 1, pp. 21–30, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. G. Z. Cheng, S. Park, S. Shu et al., “Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery,” Current Cancer Drug Targets, vol. 8, no. 1, pp. 2–6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. B. Vanhaesebroeck, J. Guillermet-Guibert, M. Graupera, and B. Bilanges, “The emerging mechanisms of isoform-specific PI3K signalling,” Nature Reviews Molecular Cell Biology, vol. 11, no. 5, pp. 329–341, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. J. M. Kyriakis and J. Avruch, “Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation,” Physiological Reviews, vol. 81, no. 2, pp. 807–869, 2001. View at Google Scholar · View at Scopus
  96. P. P. Roux and J. Blenis, “ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions,” Microbiology and Molecular Biology Reviews, vol. 68, no. 2, pp. 320–344, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. P. J. Roberts and C. J. Der, “Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer,” Oncogene, vol. 26, no. 22, pp. 3291–3310, 2007. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Raman, W. Chen, and M. H. Cobb, “Differential regulation and properties of MAPKs,” Oncogene, vol. 26, no. 22, pp. 3100–3112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. E. K. Kim and E. J. Choi, “Pathological roles of MAPK signaling pathways in human diseases,” Biochimica et Biophysica Acta, vol. 1802, no. 4, pp. 396–405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. D. G. Stupack, “The biology of integrins,” Oncology, vol. 21, no. 9, supplement 3, pp. 6–12, 2007. View at Google Scholar · View at Scopus
  101. P. H. Vachon, “Cell survival: differences and differentiation,” Medecine/Sciences, vol. 22, no. 4, pp. 423–429, 2006. View at Google Scholar · View at Scopus
  102. J. Boudeau, D. Miranda-Saavedra, G. J. Barton, and D. R. Alessi, “Emerging roles of pseudokinases,” Trends in Cell Biology, vol. 16, no. 9, pp. 443–452, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. S. A. Wickström, A. Lange, E. Montanez, and R. Fässler, “The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase!,” EMBO Journal, vol. 29, no. 2, pp. 281–291, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. A. B. Fielding and S. Dedhar, “The mitotic functions of integrin-linked kinase,” Cancer and Metastasis Reviews, vol. 28, no. 1-2, pp. 99–111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. C. Wellbrock, M. Karasarides, and R. Marais, “The RAF proteins take centre stage,” Nature Reviews Molecular Cell Biology, vol. 5, no. 11, pp. 875–885, 2004. View at Publisher · View at Google Scholar · View at Scopus
  106. A. Carriere, H. Ray, J. Blenis, and P. P. Roux, “The RSK factors of activating the Ras/MAPK signaling cascade,” Frontiers in Bioscience, vol. 13, no. 11, pp. 4258–4275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. R. Anjum and J. Blenis, “The RSK family of kinases: emerging roles in cellular signalling,” Nature Reviews Molecular Cell Biology, vol. 9, no. 10, pp. 747–758, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. S. M. Frisch, “Caspase-8: fly or die,” Cancer Research, vol. 68, no. 12, pp. 4491–4493, 2008. View at Publisher · View at Google Scholar · View at Scopus
  109. E. Kurenova, L. H. Xu, X. Yang et al., “Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein,” Molecular and Cellular Biology, vol. 24, no. 10, pp. 4361–4371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  110. P. Kamarajan, J. Bunek, Y. Lin, G. Nunez, and Y. L. Kapila, “Receptor-interacting protein shuttles between cell death and survival signaling pathways,” Molecular Biology of the Cell, vol. 21, no. 3, pp. 481–488, 2010. View at Publisher · View at Google Scholar
  111. E. Gonzalez and T. E. McGraw, “The Akt kinases: isoform specificity in metabolism and cancer,” Cell Cycle, vol. 8, no. 16, pp. 2502–2508, 2009. View at Google Scholar · View at Scopus
  112. B. Giovannone, M. L. Scaldaferri, M. Federici et al., “Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential,” Diabetes/Metabolism Research and Reviews, vol. 16, no. 6, pp. 434–441, 2000. View at Google Scholar
  113. M. Pellegrini, S. Pacini, and C. T. Baldari, “p66SHC: the apoptotic side of Shc,” Apoptosis, vol. 10, no. 1, pp. 13–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  114. S. M. Frisch and E. Ruoslahti, “Integrins and anoikis,” Current Opinion in Cell Biology, vol. 9, no. 5, pp. 701–706, 1997. View at Publisher · View at Google Scholar · View at Scopus
  115. S. M. Frisch and R. A. Screaton, “Anoikis mechanisms,” Current Opinion in Cell Biology, vol. 13, no. 5, pp. 555–562, 2001. View at Publisher · View at Google Scholar · View at Scopus
  116. L. A. Liotta and E. Kohn, “Cancer and the homeless cell,” Nature, vol. 430, no. 7003, pp. 973–974, 2004. View at Publisher · View at Google Scholar · View at Scopus
  117. A. P. Gilmore, “Anoikis,” Cell Death and Differentiation, vol. 12, supplement 2, pp. 1473–1477, 2005. View at Publisher · View at Google Scholar · View at Scopus
  118. P. Chiarugi and E. Giannoni, “Anoikis: a necessary death program for anchorage-dependent cells,” Biochemical Pharmacology, vol. 76, no. 11, pp. 1352–1364, 2008. View at Publisher · View at Google Scholar · View at Scopus
  119. C. D. Simpson, K. Anyiwe, and A. D. Schimmer, “Anoikis resistance and tumor metastasis,” Cancer Letters, vol. 272, no. 2, pp. 177–185, 2008. View at Publisher · View at Google Scholar · View at Scopus
  120. C. Horbinski, C. Mojesky, and N. Kyprianou, “Live free or die: tales of homeless (cells) in cancer,” American Journal of Pathology, vol. 177, no. 3, pp. 1044–1052, 2010. View at Publisher · View at Google Scholar
  121. C. H. Streuli and A. P. Gilmore, “Adhesion-mediated signaling in the regulation of mammary epithelial cell survival,” Journal of Mammary Gland Biology and Neoplasia, vol. 4, no. 2, pp. 183–191, 1999. View at Google Scholar · View at Scopus
  122. C. H. Streuli, “Integrins and cell-fate determination,” Journal of Cell Science, vol. 122, no. 2, pp. 171–177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  123. E. Houben, K. De Paepe, and V. Rogiers, “A keratinocyte's course of life,” Skin Pharmacology and Physiology, vol. 20, no. 3, pp. 122–132, 2007. View at Publisher · View at Google Scholar · View at Scopus
  124. E. J. Müller, L. Williamson, C. Kolly, and M. M. Suter, “Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation?” Journal of Investigative Dermatology, vol. 128, no. 3, pp. 501–516, 2008. View at Publisher · View at Google Scholar
  125. D. Ménard, J.-F. Beaulieu, F. Boudreau, N. Perreault, N. Rivard, and P. H. Vachon, “Gastrointestinal tract (GI Tract),” in Cell Signaling and Growth Factors in Development—Part II, K. Unsicker and K. Krieglstein, Eds., pp. 755–790, Wiley-VCH, Cambridge, UK, 2005. View at Google Scholar
  126. K. L. Edelblum, F. Yan, T. Yamaoka, and D. B. Polk, “Regulation of apoptosis during homeostasis and disease in the intestinal epithelium,” Inflammatory Bowel Diseases, vol. 12, no. 5, pp. 413–424, 2006. View at Publisher · View at Google Scholar · View at Scopus
  127. Z. Ma, D. P. Myers, F. W. Ru, F. E. Nwariaku, and L. S. Terada, “p66SHC mediates anoikis through RhoA,” Journal of Cell Biology, vol. 179, no. 1, pp. 23–31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  128. S. M. Frisch, “Anoikis,” Methods in Enzymology, vol. 322, pp. 472–479, 2000. View at Google Scholar · View at Scopus
  129. M. A. Bogoyevitch, “The isoform-specific functions of the c-Jun N-terminal kinases (JNKs): differences revealed by gene targeting,” BioEssays, vol. 28, no. 9, pp. 923–934, 2006. View at Publisher · View at Google Scholar · View at Scopus
  130. M. A. Bogoyevitch and B. Kobe, “Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases,” Microbiology and Molecular Biology Reviews, vol. 70, no. 4, pp. 1061–1095, 2006. View at Publisher · View at Google Scholar · View at Scopus
  131. A. M. Bode and Z. Dong, “The functional contrariety of JNK,” Molecular Carcinogenesis, vol. 46, no. 8, pp. 591–598, 2007. View at Publisher · View at Google Scholar · View at Scopus
  132. M. Loesch and G. Chen, “The p38 MAPK stress pathway as a tumor suppressor or more?” Frontiers in Bioscience, vol. 13, no. 9, pp. 3581–3593, 2008. View at Publisher · View at Google Scholar · View at Scopus
  133. E. F. Wagner and A. R. Nebreda, “Signal integration by JNK and p38 MAPK pathways in cancer development,” Nature Reviews Cancer, vol. 9, no. 8, pp. 537–549, 2009. View at Publisher · View at Google Scholar · View at Scopus
  134. A. Cuadrado and A. R. Nebreda, “Mechanisms and functions of p38 MAPK signalling,” Biochemical Journal, vol. 429, no. 3, pp. 403–417, 2010. View at Publisher · View at Google Scholar
  135. J. Liu and A. Lin, “Role of JNK activation in apoptosis: a double-edged sword,” Cell Research, vol. 15, no. 1, pp. 36–42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  136. T. Zarubin and J. Han, “Activation and signaling of the p38 MAP kinase pathway,” Cell Research, vol. 15, no. 1, pp. 11–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  137. S. M. Frisch, K. Vuori, D. Kelaita, and S. Sicks, “A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crmA,” Journal of Cell Biology, vol. 135, no. 5, pp. 1377–1382, 1996. View at Publisher · View at Google Scholar · View at Scopus
  138. M. H. Cardone, G. S. Salvesen, C. Widmann, G. Johnson, and S. M. Frisch, “The regulation of anoikis: MEKK-1 activation requires cleavage by caspases,” Cell, vol. 90, no. 2, pp. 315–323, 1997. View at Publisher · View at Google Scholar · View at Scopus
  139. A. Khwaja and J. Downward, “Lack of correlation between activation of Jun-NH2-terminal kinase and induction of apoptosis after detachment of epithelial cells,” Journal of Cell Biology, vol. 139, no. 4, pp. 1017–1023, 1997. View at Publisher · View at Google Scholar
  140. Y. Wang, S. Huang, V. P. Sah et al., “Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family,” Journal of Biological Chemistry, vol. 273, no. 4, pp. 2161–2168, 1998. View at Publisher · View at Google Scholar · View at Scopus
  141. J. Matsukawa, A. Matsuzawa, K. Takeda, and H. Ichijo, “The ASK1-MAP kinase cascades in mammalian stress response,” Journal of Biochemistry, vol. 136, no. 3, pp. 261–265, 2004. View at Publisher · View at Google Scholar · View at Scopus
  142. T. Fujisawa, K. Takeda, and H. Ichijo, “ASK family proteins in stress response and disease,” Molecular Biotechnology, vol. 37, no. 1, pp. 13–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  143. S. Bialik and A. Kimchi, “The death-associated protein kinases: structure, function, and beyond,” Annual Review of Biochemistry, vol. 75, pp. 189–210, 2006. View at Publisher · View at Google Scholar · View at Scopus
  144. D. Gozuacik and A. Kimchi, “DAPk protein family and cancer,” Autophagy, vol. 2, no. 2, pp. 74–79, 2006. View at Google Scholar · View at Scopus
  145. E. Zalckvar, H. Berissi, M. Eisenstein, and A. Kimchi, “Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-X,” Autophagy, vol. 5, no. 5, pp. 720–722, 2009. View at Publisher · View at Google Scholar · View at Scopus
  146. S. Bialik and A. Kimchi, “Lethal weapons: DAP-kinase, autophagy and cell death. DAP-kinase regulates autophagy,” Current Opinion in Cell Biology, vol. 22, no. 2, pp. 199–205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  147. A. M. Michie, A. M. McCaig, R. Nakagawa, and M. Vukovic, “Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer,” FEBS Journal, vol. 277, no. 1, pp. 74–80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. Y. Lin, T. R. Hupp, and C. Stevens, “Death-associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death,” FEBS Journal, vol. 277, no. 1, pp. 48–57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  149. W. J. Wang, J. C. Kuo, C. C. Yao, and R. H. Chen, “DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals,” Journal of Cell Biology, vol. 159, no. 1, pp. 169–179, 2002. View at Publisher · View at Google Scholar · View at Scopus
  150. J. C. Kuo, J. R. Lin, J. M. Staddon, H. Hosoya, and R. H. Chen, “Uncoordinated regulation of stress fibers and focal adhesions by DAP kinase,” Journal of Cell Science, vol. 116, no. 23, pp. 4777–4790, 2003. View at Publisher · View at Google Scholar · View at Scopus
  151. J. C. Kuo, W. J. Wang, C. C. Yao, P. R. Wu, and R. H. Chen, “The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway,” Journal of Cell Biology, vol. 172, no. 4, pp. 619–631, 2006. View at Publisher · View at Google Scholar · View at Scopus
  152. D. G. Stupack, X. S. Puente, S. Boutsaboualoy, C. M. Storgard, and D. A. Cheresh, “Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins,” Journal of Cell Biology, vol. 155, no. 4, pp. 459–470, 2001. View at Google Scholar · View at Scopus
  153. R. Lotti, A. Marconi, F. Truzzi et al., “A previously unreported function of β1B integrin isoform in caspase-8-dependent integrin-mediated keratinocyte death,” Journal of Investigative Dermatology, vol. 130, no. 11, pp. 2569–2577, 2010. View at Publisher · View at Google Scholar
  154. M. Rytömaa, L. M. Martins, and J. Downward, “Involvement of FADD and caspase-8 signalling in detachment-induced apoptosis,” Current Biology, vol. 9, no. 18, pp. 1043–1046, 1999. View at Publisher · View at Google Scholar · View at Scopus
  155. S. M. Frisch, “Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis,” Current Biology, vol. 9, no. 18, pp. 1047–1049, 1999. View at Publisher · View at Google Scholar · View at Scopus
  156. A. Marconi, P. Atzei, C. Panza et al., “FLICE/caspace-8 activation triggers anoikis induced by β 1-integrin blockade in human keratinocytes,” Journal of Cell Science, vol. 117, no. 24, pp. 5815–5823, 2004. View at Publisher · View at Google Scholar
  157. M. Rytömaa, K. Lechmann, and J. Downward, “Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Raf signalling,” Oncogene, vol. 19, no. 39, pp. 4461–4468, 2000. View at Google Scholar · View at Scopus
  158. T. Miyazaki, M. Shen, D. Fujikura et al., “Functional role of death-associated protein 3 (DAP3) in anoikis,” Journal of Biological Chemistry, vol. 279, no. 43, pp. 44667–44672, 2004. View at Publisher · View at Google Scholar · View at Scopus
  159. M. Bouchentouf, B. F. Benabdallah, J. Rousseau, L. M. Schwartz, and J. P. Tremblay, “Induction of anoikis following myoblast transplantation into SCID mouse muscles requires the Bit1 and FADD pathways,” American Journal of Transplantation, vol. 7, no. 6, pp. 1491–1505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  160. I. A. Mawji, C. D. Simpson, R. Hurren et al., “Critical role for fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation,” Journal of the National Cancer Institute, vol. 99, no. 10, pp. 811–822, 2007. View at Publisher · View at Google Scholar · View at Scopus
  161. F. Aoudjit and K. Vuori, “Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-Flip and implications for anoikis,” Journal of Cell Biology, vol. 153, no. 3, pp. 633–643, 2001. View at Google Scholar · View at Scopus
  162. Y. Zhao, X. Sui, and H. Ren, “From procaspase-8 to caspase-8: revisiting structural functions of caspase-8,” Journal of Cellular Physiology, vol. 225, no. 2, pp. 316–320, 2010. View at Publisher · View at Google Scholar
  163. F. Escaffit, N. Perreault, D. Jean et al., “Repressed E-cadherin expression in the lower crypt of human small intestine: a cell marker of functional relevance,” Experimental Cell Research, vol. 302, no. 2, pp. 206–220, 2005. View at Publisher · View at Google Scholar · View at Scopus
  164. T. J. C. Harris and U. Tepass, “Adherens junctions: from molecules to morphogenesis,” Nature Reviews Molecular Cell Biology, vol. 11, no. 7, pp. 502–514, 2010. View at Publisher · View at Google Scholar · View at Scopus
  165. S. Cagnol and J. C. Chambard, “ERK and cell death: mechanisms of ERK-induced cell death—apoptosis, autophagy and senescence,” FEBS Journal, vol. 277, no. 1, pp. 2–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  166. Y. Mebratu and Y. Tesfaigzi, “How ERK1/2 activation controls cell proliferation and cell death is subcellular localization the answer?” Cell Cycle, vol. 8, no. 8, pp. 1168–1175, 2009. View at Google Scholar · View at Scopus
  167. V. Bouchard, C. Harnois, M.-J. Demers et al., “β1 integrin/Fak/Src signaling in intestinal epithelial crypt cell survival: integration of complex regulatory mechanisms,” Apoptosis, vol. 13, no. 4, pp. 531–542, 2008. View at Publisher · View at Google Scholar · View at Scopus
  168. S. M. Frisch, K. Vuori, E. Ruoslahti, and PO. Y. Chan-Hui, “Control of adhesion-dependent cell survival by focal adhesion kinase,” Journal of Cell Biology, vol. 134, no. 3, pp. 793–799, 1996. View at Google Scholar · View at Scopus
  169. Y. D. Benoit, J.-F. Larrivée, J.-F. Groulx, J. Stankova, P. H. Vachon, and J.-F. Beaulieu, “Integrin α8β1 confers anoikis susceptibility to human intestinal epithelial crypt cells,” Biochemical and Biophysical Research Communications, vol. 399, no. 3, pp. 434–439, 2010. View at Publisher · View at Google Scholar
  170. M. C. Subauste, O. Pertz, E. D. Adamson, C. E. Turner, S. Junger, and K. M. Hahn, “Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility,” Journal of Cell Biology, vol. 165, no. 3, pp. 371–381, 2004. View at Publisher · View at Google Scholar · View at Scopus
  171. W. H. Ziegler, R. C. Liddington, and D. R. Critchley, “The structure and regulation of vinculin,” Trends in Cell Biology, vol. 16, no. 9, pp. 453–460, 2006. View at Publisher · View at Google Scholar · View at Scopus
  172. N. I. Kozlova, G. E. Morozevich, A. N. Chubukina, and A. E. Berman, “Integrin αv/β3 promotes anchorage-dependent apoptosis in human intestinal carcinoma cells,” Oncogene, vol. 20, no. 34, pp. 4710–4717, 2001. View at Publisher · View at Google Scholar · View at Scopus
  173. G. E. Morozevich, N. I. Kozlova, A. N. Chubukina, and A. E. Berman, “Role of integrin αvβ3 in substrate-dependent apoptosis of human intestinal carcinoma cells,” Biochemistry, vol. 68, no. 4, pp. 416–423, 2003. View at Publisher · View at Google Scholar · View at Scopus
  174. H. Jin and J. Varner, “Integrins: roles in cancer development and as treatment targets,” British Journal of Cancer, vol. 90, no. 3, pp. 561–565, 2004. View at Publisher · View at Google Scholar · View at Scopus
  175. C. H. Streulli and N. Akhtar, “Signal co-operation between integrins and other receptor systems,” Biochemical Journal, vol. 418, no. 3, pp. 491–506, 2009. View at Publisher · View at Google Scholar
  176. E. Farias, M. Lu, X. Li, and L. M. Schnapp, “Integrin α8β1-fibronectin interactions promote cell survival via PI3 kinase pathway,” Biochemical and Biophysical Research Communications, vol. 329, no. 1, pp. 305–311, 2005. View at Publisher · View at Google Scholar · View at Scopus
  177. J.-F. Beaulieu, “Integrins and human intestinal cell functions,” Frontiers in Bioscience, vol. 4, pp. D310–D321, 1999. View at Google Scholar · View at Scopus
  178. C. Lussier, N. Basora, Y. Bouatrouss, and J.-F. Beaulieu, “Integrins as mediators of epithelial cell-matrix interactions in the human small intestinal mucosa,” Microscopy Research and Technique, vol. 51, no. 2, pp. 169–178, 2000. View at Google Scholar · View at Scopus
  179. J. Stutzmann, A. Bellissent-Waydelich, L. Fontao, J. F. Launay, and P. Simon-Assmann, “Adhesion complexes implicated in intestinal epithelial cell-matrix interactions,” Microscopy Research and Technique, vol. 51, no. 2, pp. 179–190, 2000. View at Google Scholar · View at Scopus
  180. A. S. Tarnawski and I. Szabo, “Apoptosis—programmed cell death and its relevance to gastrointestinal epithelium: survival signal from the matrix,” Gastroenterology, vol. 120, no. 1, pp. 294–298, 2001. View at Google Scholar · View at Scopus
  181. I. C. Teller, J. Auclair, E. Herring, R. Gauthier, D. Ménard, and J.-F. Beaulieu, “Laminins in the developing and adult human small intestine: relation with the functional absorptive unit,” Developmental Dynamics, vol. 236, no. 7, pp. 1980–1990, 2007. View at Publisher · View at Google Scholar · View at Scopus
  182. P. H. Vachon, E. Cardin, C. Harnois, J. C. Reed, and A. Vézina, “Early establishment of epithelial apoptosis in the developing human small intestine,” International Journal of Developmental Biology, vol. 44, no. 8, pp. 891–898, 2000. View at Google Scholar · View at Scopus
  183. P. H. Vachon, E. Cardin, C. Harnois, J. C. Reed, A. Plourde, and A. Vézina, “Early acquisition of bowel segment-specific Bcl-2 homolog expression profiles during development of the human ileum and colon,” Histology and Histopathology, vol. 16, no. 2, pp. 497–510, 2001. View at Google Scholar · View at Scopus
  184. C. S. Potten, “Epithelial cell growth and differentiation II. Intestinal apoptosis,” American Journal of Physiology, vol. 273, no. 2, part 1, pp. G253–G257, 1997. View at Google Scholar · View at Scopus
  185. R. Gauthier, C. Harnois, J.-F. Drolet, J. C. Reed, A. Vézina, and P. H. Vachon, “Human intestinal epithelial cell survival: differentiation state-specific control mechanisms,” American Journal of Physiology, vol. 280, no. 6, pp. C1540–C1554, 2001. View at Google Scholar · View at Scopus
  186. C. Harnois, M.-J. Demers, V. Bouchard et al., “Human intestinal epithelial crypt cell survival and death: complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1, MEK/Erk, and p38 signaling pathways,” Journal of Cellular Physiology, vol. 198, no. 2, pp. 209–222, 2004. View at Publisher · View at Google Scholar
  187. R. Gauthier, P. Laprise, E. Cardin et al., “Differential sensitivity to apoptosis between the human small and large intestinal mucosae: linkage with segment-specific regulation of BCL-2 homologs and involvement of signaling pathways,” Journal of Cellular Biochemistry, vol. 82, no. 2, pp. 339–355, 2001. View at Publisher · View at Google Scholar
  188. J.-F. Beaulieu, “Integrin α6β4 in colorectal cancer,” World Journal of Gastrointestinal Pathophysiology, vol. 1, no. 1, pp. 3–11, 2010. View at Google Scholar
  189. P. H. Vachon, C. Harnois, A. Grenier et al., “Differentiation state-selective roles of p38 isoforms in human intestinal epithelial cell anoikis,” Gastroenterology, vol. 123, no. 6, pp. 1980–1991, 2002. View at Publisher · View at Google Scholar · View at Scopus
  190. V. Bouchard, M.-J. Demers, S. Thibodeau et al., “Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways,” Journal of Cellular Physiology, vol. 212, no. 3, pp. 717–728, 2007. View at Publisher · View at Google Scholar · View at Scopus
  191. G. Dufour, M.-J. Demers, D. Gagné et al., “Human intestinal epithelial cell survival and anoikis: differentiation state-distinct regulation and roles of protein kinase B/Akt isoforms,” Journal of Biological Chemistry, vol. 279, no. 42, pp. 44113–44122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  192. G. M. Smythe and T. A. Rando, “Altered caveolin-3 expression disrupts PI(3) kinase signaling leading to death of cultured muscle cells,” Experimental Cell Research, vol. 312, no. 15, pp. 2816–2825, 2006. View at Publisher · View at Google Scholar · View at Scopus
  193. P. Rotwein and E. M. Wilson, “Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation,” Journal of Cellular Physiology, vol. 219, no. 2, pp. 503–511, 2009. View at Publisher · View at Google Scholar · View at Scopus
  194. D. E. Jaalouk and J. Lammerding, “Mechanotransduction gone awry,” Nature Reviews Molecular Cell Biology, vol. 10, no. 1, pp. 63–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  195. G. Q. Wallace and E. M. McNally, “Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies,” Annual Review of Physiology, vol. 71, pp. 37–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  196. E. M. McNally and P. Pytel, “Muscle diseases: the muscular dystrophies,” Annual Review of Pathology, vol. 2, pp. 87–109, 2007. View at Publisher · View at Google Scholar · View at Scopus
  197. J. Uitto, J. A. McGrath, U. Rodeck, L. Bruckner-Tuderman, and E. C. Robinson, “Progress in epidermolysis bullosa research: toward treatment and cure,” Journal of Investigative Dermatology, vol. 130, no. 7, pp. 1778–1784, 2010. View at Publisher · View at Google Scholar · View at Scopus
  198. G. Kroemer, “Cell death and cancer: an introduction,” Oncogene, vol. 23, no. 16, pp. 2743–2745, 2004. View at Publisher · View at Google Scholar · View at Scopus
  199. S. J. Shattil, C. Kim, and M. H. Ginsberg, “The final steps of integrin activation: the end game,” Nature Reviews Molecular Cell Biology, vol. 11, no. 4, pp. 288–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  200. D. Barkan, J. E. Green, and A. F. Chambers, “Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth,” European Journal of Cancer, vol. 46, no. 7, pp. 1181–1188, 2010. View at Publisher · View at Google Scholar · View at Scopus
  201. M. Guarino, “Src signaling in cancer invasion,” Journal of Cellular Physiology, vol. 223, no. 1, pp. 14–26, 2010. View at Publisher · View at Google Scholar · View at Scopus
  202. M.-J. Demers, S. Thibodeau, D. Noël et al., “Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1,” Journal of Cellular Biochemistry, vol. 107, no. 4, pp. 639–654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  203. A. Singh and J. Settleman, “EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer,” Oncogene, vol. 29, no. 34, pp. 4741–4751, 2010. View at Publisher · View at Google Scholar · View at Scopus